StockData
Incyte Corp logo

Incyte Corp (INCY) stock

INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3088% above fair value
$117.80−1.29 (-1.08%)

Close on Nov 18, 2026Market cap $24.01BP/E 62.7Yield –

Incyte revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Incyte's revenue for the twelve months ending Sep 30, 2026 was $6.01B, up 24.9% year over year. For fiscal 2025 it was $5.14B, up 21.2% from the year before. Over ten years it grew 21.2% a year on average. The highest annual figure on record is $5.14B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.14B+21.2%
FY2024Dec 31, 2024$4.24B+14.8%
FY2023Dec 31, 2023$3.70B+8.9%
FY2022Dec 31, 2022$3.39B+13.7%
FY2021Dec 31, 2021$2.99B+12.0%
FY2020Dec 31, 2020$2.67B+23.5%
FY2019Dec 31, 2019$2.16B+14.7%
FY2018Dec 31, 2018$1.88B+22.5%
FY2017Dec 31, 2017$1.54B+38.9%
FY2016Dec 31, 2016$1.11B+46.7%
FY2015Dec 31, 2015$753.75M+47.4%
FY2014Dec 31, 2014$511.50M+44.1%
FY2013Dec 31, 2013$354.95M+19.5%
FY2012Dec 31, 2012$297.06M+214.5%
FY2011Dec 31, 2011$94.46M-44.4%
FY2010Dec 31, 2010$169.88M+1733.5%
FY2009Dec 31, 2009$9.27M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.56B+14.0%
Q2 FY2026Jun 30, 2026$1.67B+37.7%
Q1 FY2026Mar 31, 2026$1.27B+20.9%
Q4 FY2025Dec 31, 2025$1.51B+27.8%
Q3 FY2025Sep 30, 2025$1.37B+20.0%
Q2 FY2025Jun 30, 2025$1.22B+16.5%
Q1 FY2025Mar 31, 2025$1.05B+19.5%
Q4 FY2024Dec 31, 2024$1.18B+16.3%
Q3 FY2024Sep 30, 2024$1.14B+23.8%
Q2 FY2024Jun 30, 2024$1.04B+9.3%
Q1 FY2024Mar 31, 2024$880.89M+8.9%
Q4 FY2023Dec 31, 2023$1.01B+9.3%
Q3 FY2023Sep 30, 2023$919.03M+11.6%
Q2 FY2023Jun 30, 2023$954.61M+4.7%
Q1 FY2023Mar 31, 2023$808.67M+10.3%
Q4 FY2022Dec 31, 2022$926.70M+7.4%
Q3 FY2022Sep 30, 2022$823.30M+1.3%
Q2 FY2022Jun 30, 2022$911.40M+29.1%
Q1 FY2022Mar 31, 2022$733.24M+21.3%
Q4 FY2021Dec 31, 2021$862.85M+9.3%
Q3 FY2021Sep 30, 2021$812.99M+31.0%
Q2 FY2021Jun 30, 2021$705.71M+2.6%
Q1 FY2021Mar 31, 2021$604.72M+6.4%
Q4 FY2020Dec 31, 2020$789.51M+36.3%
Q3 FY2020Sep 30, 2020$620.64M+12.5%
Q2 FY2020Jun 30, 2020$688.04M+29.8%
Q1 FY2020Mar 31, 2020$568.51M+14.2%
Q4 FY2019Dec 31, 2019$579.39M+9.6%
Q3 FY2019Sep 30, 2019$551.58M+22.7%
Q2 FY2019Jun 30, 2019$529.93M+1.6%
Q1 FY2019Mar 31, 2019$497.86M+30.2%
Q4 FY2018Dec 31, 2018$528.40M+19.0%
Q3 FY2018Sep 30, 2018$449.68M+17.9%
Q2 FY2018Jun 30, 2018$521.52M+59.8%
Q1 FY2018Mar 31, 2018$382.28M-0.5%
Q4 FY2017Dec 31, 2017$444.16M+36.0%
Q3 FY2017Sep 30, 2017$381.53M–
Q2 FY2017Jun 30, 2017$326.44M–
Q1 FY2017Mar 31, 2017$384.08M–
Q4 FY2016Dec 31, 2016$326.50M–

More Incyte figures

See a number that looks wrong?